Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Hesperetin is a flavonoid found in citrus fruits, characterized by its diverse biological activities and antioxidant properties. It is a trihydroxyflavanone with hydroxy groups located at the 3'-, 5-, and 7-positions and a methoxy substituent at the 4'-position. Hesperetin has a role as an antioxidant, an antineoplastic agent, and a plant metabolite. It is a monomethoxyflavanone, a trihydroxyflavanone, a member of 3'-hydroxyflavanones, and a member of 4'-methoxyflavanones.

520-33-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 520-33-2 Structure
  • Basic information

    1. Product Name: HESPERETIN
    2. Synonyms: 5,7,3'-TRIHYDROXY-4'-METHOXYFLAVANONE;4'-METHOXY-3',5,7-TRIHYDROXYFLAVANONE;(+/-)-3',5,7-TRIHYDROXY-4'-METHOXYFLAVANONE;3',5,7-TRIHYDROXY-4'-METHOXYFLAVANONE;3',5,7-TRIHYDROXY-4-METHOXYFLAVANONE;2,3-DIHYDRO-5,7-DIHYDROXY-2S-(3-HYDROXY-4-METHOXPHENYL)-4H-1-BENZOPYRAN-4-ONE;HESPERETINE;(+/-)-HESPERETIN
    3. CAS NO:520-33-2
    4. Molecular Formula: C16H14O6
    5. Molecular Weight: 302.28
    6. EINECS: 208-290-2
    7. Product Categories: Flavanones;Biochemistry;Flavonoids;Natural Plant Extract;Inhibitors;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;natural product
    8. Mol File: 520-33-2.mol
  • Chemical Properties

    1. Melting Point: 230-232°C
    2. Boiling Point: 363.32°C (rough estimate)
    3. Flash Point: 223 °C
    4. Appearance: Beige to Light Brown Crystalline Solid
    5. Density: 1.2514 (rough estimate)
    6. Vapor Pressure: 2.45E-14mmHg at 25°C
    7. Refractive Index: -4 ° (C=1.8, EtOH)
    8. Storage Temp.: 2-8°C
    9. Solubility: DMSO (Slightly), Methanol (Slightly)
    10. PKA: 7.49±0.40(Predicted)
    11. Water Solubility: Soluble in water (partly), dilute alkalis, and ethanol (50 mg/ml).
    12. Merck: 14,4670
    13. BRN: 309850
    14. CAS DataBase Reference: HESPERETIN(CAS DataBase Reference)
    15. NIST Chemistry Reference: HESPERETIN(520-33-2)
    16. EPA Substance Registry System: HESPERETIN(520-33-2)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36/37/39-27-37
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 520-33-2(Hazardous Substances Data)

520-33-2 Usage

Uses

Used in Pharmaceutical Applications:
Hesperetin is used as an antiallergic agent for its ability to inhibit IgG-induced β-hexosaminidase release from RBL-2H3 cells and reduce body weight loss, colon shortening, and ulcer severity in a mouse model of TNBS-induced ulcerative colitis.
Used in Antioxidant Applications:
Hesperetin is used as an antioxidant flavonoid for its ability to induce G1-phase cell cycle arrest, suppress NF-κB activation, reduce cholesterol biosynthesis, inhibit lipid peroxidation, and provide neuroprotection against neuronal oxidative damage.
Used in Anti-inflammatory Applications:
Hesperetin is used as an anti-inflammatory agent for its ability to inhibit LPS-induced nitric oxide (NO) production and reduce levels of inducible nitric oxide synthase (iNOS), IL-6, and IL-1β in BV-2 microglial cells.
Used in Neuroprotective Applications:
Hesperetin is used as a neuroprotective agent for its ability to reduce cortical and hippocampal neuronal apoptosis and increase time spent in the target quadrant in the Morris water maze in a mouse model of LPS-induced neuronal inflammation.
Used in Food Industry:
Hesperetin is used as a natural antioxidant and flavor enhancer in the food industry, benefiting from its presence in citrus fruits and its diverse biological activities.

Purification Methods

Crystallise it from EtOAc or ethanol. The natural S(-) form crystallises from EtOH and has m 216-218o and [] D -37.6o (c 2, EtOH). Note that C2 is chiral. [Beilstein 18 II 204, 18 III/IV 3215, 18/5 V 214.]

Check Digit Verification of cas no

The CAS Registry Mumber 520-33-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 520-33:
(5*5)+(4*2)+(3*0)+(2*3)+(1*3)=42
42 % 10 = 2
So 520-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1

520-33-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0721)  Hesperetin  >97.0%(HPLC)(T)

  • 520-33-2

  • 5g

  • 890.00CNY

  • Detail
  • TCI America

  • (H0721)  Hesperetin  >97.0%(HPLC)(T)

  • 520-33-2

  • 25g

  • 2,450.00CNY

  • Detail
  • Alfa Aesar

  • (B20528)  3',5,7-Trihydroxy-4'-methoxyflavanone, 97%   

  • 520-33-2

  • 1g

  • 279.0CNY

  • Detail
  • Alfa Aesar

  • (B20528)  3',5,7-Trihydroxy-4'-methoxyflavanone, 97%   

  • 520-33-2

  • 5g

  • 988.0CNY

  • Detail
  • Alfa Aesar

  • (B20528)  3',5,7-Trihydroxy-4'-methoxyflavanone, 97%   

  • 520-33-2

  • 25g

  • 4075.0CNY

  • Detail

520-33-2Synthetic route

hesperidin
520-26-3

hesperidin

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With sulfuric acid; acetic acid In water for 12h; Reflux;98%
With sulfuric acid In water at 121℃; for 4h; High pressure;87%
With sulfuric acid In ethanol for 8h; Reflux;87%
7-hydroxy-4-methyl-chromen-2-one
90-33-5, 79566-13-5

7-hydroxy-4-methyl-chromen-2-one

hesperidin
520-26-3

hesperidin

A

4-methylumbelliferyl-rutinoside
1356391-89-3

4-methylumbelliferyl-rutinoside

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water In dimethyl sulfoxide at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;A 28%
B n/a
hesperidin
520-26-3

hesperidin

A

hesperetin
520-33-2

hesperetin

B

3′,5,7,8-tetrahydroxy-4′-methoxyflavanone

3′,5,7,8-tetrahydroxy-4′-methoxyflavanone

Conditions
ConditionsYield
With Aspergillus saitoi In water; dimethyl sulfoxide at 30℃; pH=5.0;A n/a
B 3.5%
hesperidin
520-26-3

hesperidin

A

(S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone
520-33-2

(S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With sulfuric acid; ethylene glycol
With sulfuric acid
With methanol; sulfuric acid
hesperidin
520-26-3

hesperidin

A

D-Glucose
2280-44-6

D-Glucose

B

L-rhamnose
73-34-7

L-rhamnose

C

hesperetin 7‐O‐β‐D‐glucopyranoside

hesperetin 7‐O‐β‐D‐glucopyranoside

D

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With sulfuric acid In water at 140℃; for 1h; Kinetics; Product distribution; Further Variations:; pH-values; Reagents; Temperatures; Hydrolysis;
hesperidin
520-26-3

hesperidin

A

hesperetin-7-glucoside

hesperetin-7-glucoside

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
L. acidophilus NCC 3010 crude extract for 4 - 8h; pH=4 - 6; Product distribution / selectivity; Enzymatic reaction;
L. plantarum NCC 1313 crude extract for 4 - 8h; pH=4 - 6; Product distribution / selectivity; Enzymatic reaction;
4G-α-D-glucopyranosyl hesperidin
161713-86-6

4G-α-D-glucopyranosyl hesperidin

A

hesperidin
520-26-3

hesperidin

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With small intestine homogenate of rat at 37℃; for 4h; Title compound not separated from byproducts.;
concentrated H2 SO4

concentrated H2 SO4

hesperidin
520-26-3

hesperidin

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
In methanol; water
(S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone
520-33-2

(S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone

A

(R)-4'-methoxy-3',5,7-trihydroxyflavanone
24604-97-5

(R)-4'-methoxy-3',5,7-trihydroxyflavanone

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With ammonium acetate In water; isopropyl alcohol pH=5; Resolution of racemate;
With per(4-chloro-3-methyl)phenylcarbamate β-cyclodextrin clicked onto an alkynyl surface modified silica support In ethanol; hexane at 25℃; Resolution of racemate;
methanol
67-56-1

methanol

hesperidin
520-26-3

hesperidin

A

C13H24O10
184239-14-3

C13H24O10

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
propan-1-ol
71-23-8

propan-1-ol

hesperidin
520-26-3

hesperidin

A

C15H28O10
168172-05-2

C15H28O10

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
ethanol
64-17-5

ethanol

hesperidin
520-26-3

hesperidin

A

ethyl α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside
187539-57-7

ethyl α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
2-methyl-propan-1-ol
78-83-1

2-methyl-propan-1-ol

hesperidin
520-26-3

hesperidin

A

C16H30O10

C16H30O10

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
pentan-1-ol
71-41-0

pentan-1-ol

hesperidin
520-26-3

hesperidin

A

C17H32O10
189187-99-3

C17H32O10

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
isopropyl alcohol
67-63-0

isopropyl alcohol

hesperidin
520-26-3

hesperidin

A

C15H28O10
1174639-57-6

C15H28O10

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
Conditions
ConditionsYield
With water at 60℃; for 0.5h; pH=5; aq. buffer; Enzymatic reaction;
With ethanol; α-rhamnosyl-β-glucosidase at 30℃; for 2h; Enzymatic reaction;
With α-rhamnosyl-β-glucosidase; water Enzymatic reaction;
With sulfuric acid In methanol; water for 6h; Reflux;
With 6-O-α-rhamnosyl-β-glucosidase from Acremonium sp. DSM24697; choline chloride; urea In aq. phosphate buffer at 60℃; for 1h; pH=6; Reagent/catalyst; Enzymatic reaction;
hesperidin
520-26-3

hesperidin

benzyl alcohol
100-51-6

benzyl alcohol

A

1′-O-benzyl-α-L-rhamnopyranosyl-(1″→6′)-β-D-glucopyranoside
88510-10-5

1′-O-benzyl-α-L-rhamnopyranosyl-(1″→6′)-β-D-glucopyranoside

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
hesperidin
520-26-3

hesperidin

butan-1-ol
71-36-3

butan-1-ol

A

n-butyl α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside

n-butyl α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;
hesperetin 7‐O‐β‐D‐glucopyranoside

hesperetin 7‐O‐β‐D‐glucopyranoside

A

β-D-glucose
492-61-5

β-D-glucose

B

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With water Enzymatic reaction;
Conditions
ConditionsYield
With solid phase supported Acremonium sp. DSM24697 α-rhamnosyl-β-glucosidase at 60℃; for 1h; pH=5; Kinetics; aq. buffer; Enzymatic reaction;
Conditions
ConditionsYield
With sulfuric acid In methanol; water for 6h; Reflux;
hesperetin 7‐O‐β‐D‐glucopyranoside

hesperetin 7‐O‐β‐D‐glucopyranoside

hesperetin
520-33-2

hesperetin

Conditions
ConditionsYield
With β-D-glucosidase In aq. buffer at 50 - 100℃; for 0.583333h; pH=4; Kinetics; Enzymatic reaction;
Conditions
ConditionsYield
With DL-dithiothreitol; recombinant Plagiochasma appendiculatum flavone 6-O-methyltransferase; magnesium chloride In aq. buffer at 37℃; for 0.5h; pH=7.5; Enzymatic reaction;
hesperetin
520-33-2

hesperetin

diosmetin
520-34-3

diosmetin

Conditions
ConditionsYield
With pyridine; iodine at 90℃; for 22h;100%
With iodine In pyridine at 90℃; for 8h;85%
With pyridine; iodine at 90 - 95℃;
With trifluoroacetic anhydride; potassium iodide In dimethyl sulfoxide; N,N-dimethyl-formamide at 100 - 120℃; for 4h; Temperature; Reagent/catalyst;37.6 g
1-deoxy-1-fluoro-α-D-glucose
2106-10-7

1-deoxy-1-fluoro-α-D-glucose

hesperetin
520-33-2

hesperetin

hesperetin 7-α-O-glucoside

hesperetin 7-α-O-glucoside

Conditions
ConditionsYield
With α-glucosidase from sulfolobus solfataricus In dimethyl sulfoxide at 45℃; for 2h; pH=9; Enzymatic reaction;99%
temozolomide
85622-93-1

temozolomide

hesperetin
520-33-2

hesperetin

C6H6N6O2*C16H14O6

C6H6N6O2*C16H14O6

Conditions
ConditionsYield
In ethanol for 1h;94%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

hesperetin
520-33-2

hesperetin

3',5,7-tri-O-tert-butyldimethylsilylhesperetin

3',5,7-tri-O-tert-butyldimethylsilylhesperetin

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 20℃; silylation;89%
2-Hydroxybenzoylhydrazine
936-02-7

2-Hydroxybenzoylhydrazine

hesperetin
520-33-2

hesperetin

hesperetin (2-hydroxybenzoyl)hydrazone
1261060-91-6

hesperetin (2-hydroxybenzoyl)hydrazone

Conditions
ConditionsYield
With acetic acid In ethanol for 24h; Reflux;83.6%
benzenesulfonic acid
98-11-3

benzenesulfonic acid

hesperetin
520-33-2

hesperetin

(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochroman-7-yl benzenesulfonate

(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochroman-7-yl benzenesulfonate

Conditions
ConditionsYield
With sodium carbonate; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 100℃; for 6h;80.9%
hesperetin
520-33-2

hesperetin

3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxyphenyl)propan-1 -one
35400-60-3

3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxyphenyl)propan-1 -one

Conditions
ConditionsYield
With potassium hydroxide; hydrogen; palladium on activated charcoal at 30℃; under 2280 Torr; for 0.5h;80%
formaldehyd
50-00-0

formaldehyd

4-(2-(piperazin-1-yl)ethyl)morpholine
4892-89-1

4-(2-(piperazin-1-yl)ethyl)morpholine

hesperetin
520-33-2

hesperetin

6-[4-(2-morpholin-4-ylethyl)piperazine-1-yl]methyl-3',5,7-trihydroxyflavanone

6-[4-(2-morpholin-4-ylethyl)piperazine-1-yl]methyl-3',5,7-trihydroxyflavanone

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;80%
o-trifluoromethylbenzyl bromide
395-44-8

o-trifluoromethylbenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[2-(trifluoromethyl)benzyl]oxy}chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[2-(trifluoromethyl)benzyl]oxy}chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;80%
4-ethylpiperazine
5308-25-8

4-ethylpiperazine

formaldehyd
50-00-0

formaldehyd

hesperetin
520-33-2

hesperetin

C23H28N2O6

C23H28N2O6

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;79%
formaldehyd
50-00-0

formaldehyd

tert-butylamine
75-64-9

tert-butylamine

hesperetin
520-33-2

hesperetin

C21H25NO6

C21H25NO6

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;78%
formaldehyd
50-00-0

formaldehyd

phenethylamine
64-04-0

phenethylamine

hesperetin
520-33-2

hesperetin

C25H25NO6

C25H25NO6

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;78%
4-Fluorobenzyl bromide
459-46-1

4-Fluorobenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-7-[(4-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

(S)-7-[(4-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;78%
1-bromomethyl-3-trifluoromethylbenzene
402-23-3

1-bromomethyl-3-trifluoromethylbenzene

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[3-(trifluoromethyl)benzyl]oxy}chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[3-(trifluoromethyl)benzyl]oxy}chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;78%
4-bromomethyltrifluoromethylbenzene
402-49-3

4-bromomethyltrifluoromethylbenzene

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[4-(trifluoromethyl)benzyl]oxy}chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[4-(trifluoromethyl)benzyl]oxy}chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;77%
propyl bromide
106-94-5

propyl bromide

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-propoxychroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-propoxychroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;75%
1-(Bromomethyl)-3-fluorobenzene
456-41-7

1-(Bromomethyl)-3-fluorobenzene

hesperetin
520-33-2

hesperetin

(S)-7-[(3-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

(S)-7-[(3-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;75%
2-methylbenzyl bromide
89-92-9

2-methylbenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2-methylbenzyl)oxy]chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2-methylbenzyl)oxy]chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;74%
formaldehyd
50-00-0

formaldehyd

isopropylamine
75-31-0

isopropylamine

hesperetin
520-33-2

hesperetin

C20H23NO6

C20H23NO6

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;73%
4-Methylbenzyl bromide
104-81-4

4-Methylbenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(4-methylbenzyl)oxy]chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(4-methylbenzyl)oxy]chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;73%
o-fluorobenzyl bromide
446-48-0

o-fluorobenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-7-[(2-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

(S)-7-[(2-fluorobenzyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;72%
benzyl bromide
100-39-0

benzyl bromide

hesperetin
520-33-2

hesperetin

(S)-7-(benzyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one
1403990-90-8

(S)-7-(benzyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;71%
With potassium carbonate In acetone at 56℃; for 10.5h;70.1%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

formaldehyd
50-00-0

formaldehyd

hesperetin
520-33-2

hesperetin

C22H26N2O6

C22H26N2O6

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;70%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

hesperetin
520-33-2

hesperetin

7-O-(2-ethoxy-2-oxoethyl)hesperetin

7-O-(2-ethoxy-2-oxoethyl)hesperetin

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In ethanol for 1h; Reflux;70%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.333333h;68%
With potassium carbonate; potassium hydrogencarbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;50%
Stage #1: hesperetin With potassium carbonate; potassium hydrogencarbonate In N,N-dimethyl-formamide at 25℃; for 0.5h;
Stage #2: ethyl bromoacetate In N,N-dimethyl-formamide for 1h;
50%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.333333h;
4-cyanobenzyl bromide
17201-43-3

4-cyanobenzyl bromide

hesperetin
520-33-2

hesperetin

(S)-4-{[(5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochroman-7-yl)oxy]methyl}benzonitrile

(S)-4-{[(5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochroman-7-yl)oxy]methyl}benzonitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;70%
C35H56O5
1186389-76-3

C35H56O5

hesperetin
520-33-2

hesperetin

C51H68O10
1314678-14-2

C51H68O10

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 60℃; for 2.5h; Inert atmosphere;68%
ethyl crotonate
10544-63-5

ethyl crotonate

hesperetin
520-33-2

hesperetin

C22H22O8

C22H22O8

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;68%
1-(2-hydroxyethyl)piperazine
103-76-4

1-(2-hydroxyethyl)piperazine

formaldehyd
50-00-0

formaldehyd

hesperetin
520-33-2

hesperetin

C23H28N2O7

C23H28N2O7

Conditions
ConditionsYield
In methanol; water for 0.5h; Mannich Aminomethylation;67%
1-bromomethyl-3-methyl-benzene
620-13-3

1-bromomethyl-3-methyl-benzene

hesperetin
520-33-2

hesperetin

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(3-methylbenzyl)oxy]chroman-4-one

(S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(3-methylbenzyl)oxy]chroman-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Alkaline conditions;67%

520-33-2Relevant articles and documents

Discovery of Novel Bacterial Chalcone Isomerases by a Sequence-Structure-Function-Evolution Strategy for Enzymatic Synthesis of (S)-Flavanones

Bornscheuer, Uwe T.,Brückner, Stephan I.,Gei?ler, Torsten,Gross, Egon,Hartmann, Beate,Ley, Jakob P.,Meinert, Hannes,R?ttger, Carsten,Schuiten, Eva,Yi, Dong,Zirpel, Bastian

supporting information, p. 16874 - 16879 (2021/07/06)

Chalcone isomerase (CHI) is a key enzyme in the biosynthesis of flavonoids in plants. The first bacterial CHI (CHIera) was identified from Eubacterium ramulus, but its distribution, evolutionary source, substrate scope, and stereoselectivity are still unclear. Here, we describe the identification of 66 novel bacterial CHIs from Genbank using a novel Sequence-Structure-Function-Evolution (SSFE) strategy. These novel bacterial CHIs show diversity in substrate specificity towards various hydroxylated and methoxylated chalcones. The mutagenesis of CHIera according to the substrate binding models of these novel bacterial CHIs resulted in several variants with greatly improved activity towards these chalcones. Furthermore, the preparative scale conversion catalyzed by bacterial CHIs has been performed for five chalcones and revealed (S)-selectivity with up to 96 % ee, which provides an alternative biocatalytic route for the synthesis of (S)-flavanones in high yields.

Design and synthesis of 7-O-1,2,3-triazole hesperetin derivatives to relieve inflammation of acute liver injury in mice

Zheng, Yan,Zhang, Yi-long,Li, Zeng,Shi, Wen,Ji, Ya-ru,Guo, Ya-Hui,Huang, Cheng,Sun, Guo-ping,Li, Jun

, (2021/01/25)

Based on the previous research results of our research group, to further improve the anti-inflammatory activity of hesperetin, we substituted triazole at the 7-OH branch of hesperetin. We also evaluated the anti-inflammatory activity of 39 new hesperetin derivatives. All compounds showed inhibitory effects on nitric oxide (NO) and inflammatory factors in lipopolysaccharide-induced RAW264.7 cells. Compound d5 showed a strong inhibitory effect on NO (half maximal inhibitory concentration = 2.34 ± 0.7 μM) and tumor necrosis factor-α, interleukin (IL)-1β, and (IL-6). Structure–activity relationships indicate that 7-O-triazole is buried in a medium-sized hydrophobic cavity that binds to the receptor. Compound d5 can also reduce the reactive oxygen species production and significantly inhibit the expression of inducible NO synthase and cyclooxygenase-2 through the nuclear factor-κB signaling pathway. In vivo results indicate that d5 can reduce liver inflammation in mice with acute liver injury (ALI) induced by CCI4. In conclusion, d5 may be a candidate drug for treating inflammation associated with ALI.

Enhanced antioxidant, anti-inflammatory and α-glucosidase inhibitory activities of citrus hesperidin by acid-catalyzed hydrolysis

Lu, Shengmin,Xing, Jianrong,Zheng, Meiyu

, (2020/08/05)

Hesperidin hydrolysates (HHS) was produced by the hydrolysis of hesperidin (HDN) in previous studies. The potential components in HHS were identified by LC-MS, and minor components (MCS) in HHS were isolated. Antioxidant activities by radical-scavenging capacities, reducing capacity and β-carotene-linoleate assay, anti-inflammatory effects by inhibiting NO production of RAW 264.7 cells, and α-glucosidase inhibitory effects of HDN, HHS, MCS and henperetin (HTN) were investigated in present study. HHS showed higher radical scavenging activities, higher reducing capacity, and higher inhibitory activity in the β-carotene-linoleate assay than HDN. HHS inhibited the production of NO and pro-inflammatory cytokines of RAW 264.7 cells more strongly than HDN. HHS also intensively inhibited α-glucosidase activity whereas HDN showed little activity. In addition, the effects of MCS on above activities showed it play a synergistic part with HTN. This work suggested that hydrolyzation of HDN enhance the activities, and provided valuable information on effective utilization of HDN.

Hesperetin as an inhibitor of the snake venom serine protease from Bothrops jararaca

dos Santos, Roney Vander,Grillo, Giovanna,Fonseca, Henrique,Stanisic, Danijela,Tasic, Ljubica

, p. 64 - 72 (2021/05/13)

The majority (90%) of the snakebite envenomation in Brazil accounts for Bothrops from the Viperidae family. Some snake venom serine proteases provoke blood coagulation in ophidian accident victims because of their fibrinolytic activity, one of those proteases from Bothrops jararaca (B. jararaca) has been chosen for this study. Our objectives were to isolate and characterize the target serine protease; isolate, purify, and characterize the orange bagasse flavone (hesperetin, Hst), and investigate the interactions between the targets, enzyme, and hesperetin. The purified serine protease was named BjSP24 because of its molecular mass and proteolytic activity. BjSP24 was folded and characterized using circular dichroism and showed low alpha-helix contents (7.7%). BjSP24 exhibited sequence similarity to other known snake venom serine proteases as measured in the enzyme tryptic peptides' LC-MS/MS run. Hesperetin was obtained within the expected yield and with the predominance of 2S isomer (82%). It acted as a mixed inhibitor for the serine protease (SVSP) from Bothrops jararaca snake venom observed in three different in vitro experiments, fluorescence, kinetics, and SSTD-NMR. It is still to determine if hesperetin might aid-in reverting the on site blood clotting problems just after snakebite accidents.

Synthesis of 5-Hydroxy-3′,4′,7-trimethoxyflavone and Related Compounds and Elucidation of Their Reversal Effects on BCRP/ABCG2-Mediated Anticancer Drug Resistance

Tsunekawa, Ryuji,Katayama, Kazuhiro,Hanaya, Kengo,Higashibayashi, Shuhei,Sugimoto, Yoshikazu,Sugai, Takeshi

, p. 210 - 220 (2018/10/15)

3′,4′,7-Trimethoxyflavone (TMF) has been reported to show a potent reversal effect on drug resistance mediated by breast cancer resistance protein (BCRP)/ATP-binding cassette subfamily G member 2 (ABCG2). In this study, we designed and synthesized five derivatives with either a hydroxy group or a fluorine atom at C-5 and several kinds of capping moiety at the C-7 hydroxy group, on the same 3′,4′-dimethoxy-substituted flavone skeleton. We subsequently evaluated the efficacies of these compounds against BCRP-expressing human leukaemia K562/BCRP cells. Reversal of drug resistance was expressed as the concentration of compound causing a twofold reduction in drug sensitivity (RI50). Of the synthesized compounds, the reversal effect of 5-hydroxy-3′,4′,7-trimethoxyflavone (HTMF, RI50 7.2 nm) towards 7-ethyl-10-hydroxycamptothecin (SN-38) was stronger than that of TMF (RI50 18 nm). Fluoro-substituted 5-fluoro-3′,4′,7-trimethoxyflavone (FTMF, RI50 25 nm) and monoglycosylated 7-(β-glucosyloxy)-5-hydroxy-3′,4′-dimethoxyflavone (GOHDMF, 91 nm) also exhibited reversal effects, whereas the di- and triglycoside derivatives did not. TMF, HTMF and FTMF at 0.01–10 μm upregulated the K562/BCRP cellular accumulation of Hoechst 33342 nuclear staining dye. In addition, western blotting revealed that treatment of K562/BCRP cells with 0.1 μm TMF, HTMF or FTMT suppressed the expression of BCRP. HTMF showed the strongest inhibition of BCRP-mediated efflux and suppression of BCRP expression of the three effective synthesized flavones.

7-O-amido substituted hesperidin derivative and preparation method and application thereof

-

Paragraph 0036-0041, (2019/11/12)

The invention discloses a 7-O-amido substituted hesperidin derivative and a preparation method and application thereof. The 7-O-amido substituted hesperidin derivative has the structural formula shownin a formula (I) (please see the specification for the formula (I)). Further pharmacological activity studies show that the related amido substituted hesperidin derivative can inhibit the release ofNO in a concentration dependency mode, production of inflammatory mediators of IL-6 and TNF-alpha is reduced, and compared with indomethacin and celecoxib, a compound 4d shows better inhibition of inflammatory activity, and significantly inhibits expression of nitric oxide synthase (iNOS) and COX-2; and the compound has the potential and value for development into anti-inflammatory drugs, and thecompound 4d is expected to be a candidate drug with the anti-inflammatory activity.

Design, synthesis and investigation of the potential anti-inflammatory activity of 7-O-amide hesperetin derivatives

Zhang, Yilong,Zheng, Yan,Shi, Wen,Guo, Yahui,Xu, Tao,Li, Zeng,Huang, Cheng,Li, Jun

, (2019/11/02)

To develop new anti-inflammatory agents, a series of 7-O-amide hesperetin derivatives was designed, synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. All compounds showed inhibitory effect on LPS-induced NO production. Among them, 7-O-(2-(Propylamino)-2-oxoethyl)hesperetin (4d) and 7-O-(2-(Cyclopentylamino)-2-oxoethyl)hesperetin (4k) with hydrophobic side chains exhibited the most potent NO inhibitory activity (IC50 = 19.32 and 16.63 μM, respectively), showing stronger inhibitory effect on the production of pro- inflammatory cytokines tumor necrosis factor (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) than indomethacin and celecoxib at 10 μM. The structure-activity relationships (SARs) suggested that the 7-O-amide unit was buried in a medium-sized hydrophobic cavity of the bound receptor. Furthermore, compound 4d could also significantly suppress the expression of inducible nitric oxide synthase enzymes (iNOS) and cyclooxygenase-2 (COX-2), through the nuclear factor-kappa B (NF-κB) signaling pathway.

Design, synthesis and investigation of potential anti-inflammatory activity of O-alkyl and O-benzyl hesperetin derivatives

Huang, Ai-Ling,Zhang, Yi-Long,Ding, Hai-Wen,Li, Bo,Huang, Cheng,Meng, Xiao-Ming,Li, Jun

, p. 82 - 91 (2018/06/01)

Hesperetin has been known to exert several activities such as anti-oxidant, antitumor and anti-inflammatory. To find hesperetin derivatives showing better activity, sixteen novel hesperetin derivatives were designed and synthesized. The new obtained compo

Functionalities tuned enantioselectivity of phenylcarbamate cyclodextrin clicked chiral stationary phases in HPLC

Tang, Jian,Lin, Yuzhou,Yang, Bo,Zhou, Jie,Tang, Weihua

, p. 566 - 573 (2017/08/26)

The mixed chloro- and methyl- functionalities can greatly modulate the enantioselectivities of phenylcarbamate cyclodextrin (CD) clicked chiral stationary phases (CSPs). A comparison study is herein reported for per(4-chloro-3-methyl)phenylcarbamate and per(2-chloro-5-methyl)phenylcarbamate β-CD clicked CSPs (i.e., CCC4M3-CSP and CCC2M5-CSP). The enantioselectivity dependence on column temperature was studied in both normal-phase and reversed-phase mode high performance liquid chromatography (HPLC). The thermodynamic study revealed that the stronger intermolecular interactions can be formed between CCC4M3-CSP and chiral solutes to drive the chiral separation. The higher enantioselectivities of CCC4M3-CSP were further demonstrated with the enantioseparation of 17 model racemates in HPLC.

Enhanced antioxidant activity, antibacterial activity and hypoglycemic effect of luteolin by complexation with manganese(II) and its inhibition kinetics on xanthine oxidase

Dong, Hao,Yang, Xiaocui,He, Jiapeng,Cai, Sheng,Xiao, Kaijun,Zhu, Liang

, p. 53385 - 53395 (2017/12/02)

The present study aims to improve the biological activities of luteolin by complexation with manganese(ii). UV-visible spectroscopy, infrared spectroscopy, thermogravimetric analysis and elemental analysis were adopted to assess the relevant interaction of luteolin and manganese(ii) ions and the chelation sites. The antioxidant activity, hypoglycemic effect and antimicrobial activity of luteolin-manganese(ii) complex with respect to its parent luteolin and the inhibition effect of which on xanthine oxidase were investigated and compared. The spectroscopic data indicated that luteolin reacts with manganese(ii) cations through the chelation sites of 5-hydroxy and 4-carbonyl in two luteolin molecules. Antioxidant and antibacterial activity were enhanced after the complexation of manganese(ii) cations with luteolin. An inhibition effect assay found that luteolin and luteolin-manganese(ii) complex reversibly inhibited xanthine oxidase in a competitive manner. Luteolin-manganese(ii) complex had a more remarkable hypoglycemic effect than luteolin by increasing the glucose consumption in liver tissue.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 520-33-2